| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BMS-509744 | GDSC1000 | pan-cancer | AAC | -0.063 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | -0.042 | 0.2 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | -0.062 | 0.2 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.041 | 0.2 |
| mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.055 | 0.2 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.04 | 0.2 |
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |